Special Instructions

This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.

Limitations

The results from this or any other diagnostic kit should be used and interpreted only in the context of the overall clinical picture. A negative test result does not exclude the possibility of exposure to hepatitis B virus. Levels of anti-HBc may be undetectable both in early infection and later after infection. This is a qualitative assay; reported antibody level cannot be correlated to an endpoint titer. Assay performance characteristics have not been established for immunocompromised or immunosuppressed patients.

Biomarkers

LOINC Codes

Result Turnaround Time

Related Documents

Stability Requirements